Letter to the Editor: Patient-reported outcomes of intensity-modulated radiotherapy vs three-dimensional conformal radiotherapy in prostate cancer

doi:10.5306/wjco.120006

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 7

This Article

(1)

(2)

(0)

(10)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Correspondence

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Oncol. Jul 24, 2026; 17(7): 120006
Published online Jul 24, 2026. doi: 10.5306/wjco.120006

Letter to the Editor: Patient-reported outcomes of intensity-modulated radiotherapy vs three-dimensional conformal radiotherapy in prostate cancer

Melek Yakar

Melek Yakar, Department of Radiation Oncology, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir 26040, Türkiye

Author contributions: Yakar M reviewed the relevant literature, interpreted the findings of the discussed study, and drafted and approved the final manuscript.

Conflict-of-interest statement: The author declares no conflict of interest in publishing the manuscript.

Corresponding author: Melek Yakar, Associate Professor, Department of Radiation Oncology, Eskisehir Osmangazi University Faculty of Medicine, Odunpazarı Eskisehir, Turkey, Eskisehir 26040, Türkiye. mcakcay@ogu.edu.tr

Received: February 12, 2026
Revised: March 9, 2026
Accepted: April 22, 2026
Published online: July 24, 2026
Processing time: 162 Days and 9.6 Hours

Core Tip

Core Tip: The study by Mera et al demonstrates that patient-reported outcome measures provide crucial information regarding the impact of radiotherapy planning techniques on patients with localized prostate cancer. Comparing three-dimensional conformal radiotherapy and intensity-modulated radiotherapy, the study suggests an association between radiotherapy technique and patient-reported functional outcomes rather than a direct causal relationship. Therefore, patient-reported outcome measures are highly important tools for evaluating treatment and technological advancements from a patient-centered perspective.